Opportunistic salpingectomy: the way forward—response to Steven Narod

Por Miller, D.M., McAlpine, J.N., Gilks, C.B., Huntsman, D.G.
Publicado em 2013

KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies

Por Soulières, D., Greer, W., Magliocco, Anthony M., Huntsman, D., Young, S., Tsao, M.-S., Kamel-Reid, S.
Publicado em 2010

CDH1/E‐cadherin germline mutations in early‐onset gastric cancer

Por Bacani, J T, Soares, M, Zwingerman, R, Nicola, N di, Senz, J, Riddell, R, Huntsman, D G, Gallinger, S
Publicado em 2006

Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer

Por Ali, A M G, Dawson, S-J, Blows, F M, Provenzano, E, Ellis, I O, Baglietto, L, Huntsman, D, Caldas, C, Pharoah, P D
Publicado em 2011

The challenges of finding the gene responsible for a rare, autosomal dominant gastric cancer susceptibility syndrome

Por Li, JJ, Healey, S, Phillips, K, Makunin, I, Wayte, N, Schrader, I, Worthley, D, Lindor, N, Huntsman, D, Goldgar, D, Suthers, G, Chenevix-Trench, G
Publicado em 2012

Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients

Por Keller, G, Vogelsang, H, Becker, I, Plaschke, S, Ott, K, Suriano, G, Mateus, A, Seruca, R, Biedermann, K, Huntsman, D, Doring, C, Holinski-Feder, E, Neutzling, A, Siewert, J, Hofler, H
Publicado em 2004

Germline E‐cadherin mutations in familial lobular breast cancer

Por Masciari, S, Larsson, N, Senz, J, Boyd, N, Kaurah, P, Kandel, M J, Harris, L N, Pinheiro, H C, Troussard, A, Miron, P, Tung, N, Oliveira, C, Collins, L, Schnitt, S, Garber, J E, Huntsman, D
Publicado em 2007

A clinically applicable molecular-based classification for endometrial cancers

Por Talhouk, A, McConechy, M K, Leung, S, Li-Chang, H H, Kwon, J S, Melnyk, N, Yang, W, Senz, J, Boyd, N, Karnezis, A N, Huntsman, D G, Gilks, C B, McAlpine, J N
Publicado no Br J Cancer (2015)

DICER1 hotspot mutations in non-epithelial gonadal tumours

Por Witkowski, L, Mattina, J, Schönberger, S, Murray, M J, Huntsman, D G, Reis-Filho, J S, McCluggage, W G, Nicholson, J C, Coleman, N, Calaminus, G, Schneider, D T, Arseneau, J, Stewart, C J R, Foulkes, W D
Publicado em 2013

Personalized oncogenomics in the management of gastrointestinal carcinomas—early experiences from a pilot study

Por Sheffield, B.S., Tessier-Cloutier, B., Li-Chang, H., Shen, Y., Pleasance, E., Kasaian, K., Li, Y., Jones, S.J.M., Lim, H.J., Renouf, D.J., Huntsman, D.G., Yip, S., Laskin, J., Marra, M., Schaeffer, D.F.
Publicado no Curr Oncol (2016)

DICER1 hotspot mutations in non-epithelial gonadal tumours

Por Witkowski, L, Mattina, J, Schönberger, S, Murray, M J, Choong, C S, Huntsman, D G, Reis-Filho, J S, McCluggage, W G, Nicholson, J C, Coleman, N, Calaminus, G, Schneider, D T, Arseneau, J, Stewart, C J R, Foulkes, W D
Publicado em 2013

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Por Dawson, S-J, Makretsov, N, Blows, F M, Driver, K E, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, G G, McLean, C A, Callagy, G, Green, A R, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C, Pharoah, P
Publicado em 2010

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Por Dawson, S-J, Makretsov, N, Blows, F M, Driver, K E, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, G G, McLean, C A, Callagy, G, Green, A R, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C, Pharoah, P
Publicado em 2010

Familial gastric cancer: overview and guidelines for management*

Por Caldas, C., Carneiro, F., Lynch, H., Yokota, J., Wiesner, G., Powell, S., Lewis, F., Huntsman, D., Pharoah, P., Jankowski, J., MacLeod, P., Vogelsang, H., Keller, G., Park, K., Richards, F., Maher, E., Gayther, S., Oliveira, C., Grehan, N., Wight, D., Seruca, R., Roviello, F., Ponder, B., Jackson, C.
Publicado em 1999

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

Por Brooks-Wilson, A, Kaurah, P, Suriano, G, Leach, S, Senz, J, Grehan, N, Butterfield, Y, Jeyes, J, Schinas, J, Bacani, J, Kelsey, M, Ferreira, P, MacGillivray, B, MacLeod, P, Micek, M, Ford, J, Foulkes, W, Australie, K, Greenberg, C, LaPointe, M, Gilpin, C, Nikkel, S, Gilchrist, D, Hughes, R, Jackson, C, Monaghan, K, Oliveira, M, Seruca, R, Gallinger, S, Caldas, C, Huntsman, D
Publicado em 2004

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers

Por Schrader, K A, Masciari, S, Boyd, N, Salamanca, C, Senz, J, Saunders, D N, Yorida, E, Maines-Bandiera, S, Kaurah, P, Tung, N, Robson, M E, Ryan, P D, Olopade, O I, Domchek, S M, Ford, J, Isaacs, C, Brown, P, Balmana, J, Razzak, A R, Miron, P, Coffey, K, Terry, M B, John, E M, Andrulis, I L, Knight, J A, O'Malley, F P, Daly, M, Bender, P, Moore, R, Southey, M C, Hopper, J L, Garber, J E, Huntsman, D G
Publicado em 2010

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

Por Wishart, G C, Bajdik, C D, Dicks, E, Provenzano, E, Schmidt, M K, Sherman, M, Greenberg, D C, Green, A R, Gelmon, K A, Kosma, V-M, Olson, J E, Beckmann, M W, Winqvist, R, Cross, S S, Severi, G, Huntsman, D, Pylkäs, K, Ellis, I, Nielsen, T O, Giles, G, Blomqvist, C, Fasching, P A, Couch, F J, Rakha, E, Foulkes, W D, Blows, F M, Bégin, L R, van't Veer, L J, Southey, M, Nevanlinna, H, Mannermaa, A, Cox, A, Cheang, M, Baglietto, L, Caldas, C, Garcia-Closas, M, Pharoah, P D P
Publicado em 2012

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consort...

Por Köbel, M, Madore, J, Ramus, S J, Clarke, B A, Pharoah, P D P, Deen, S, Bowtell, D D, Odunsi, K, Menon, U, Morrison, C, Lele, S, Bshara, W, Sucheston, L, Beckmann, M W, Hein, A, Thiel, F C, Hartmann, A, Wachter, D L, Anglesio, M S, Høgdall, E, Jensen, A, Høgdall, C, Kalli, K R, Fridley, B L, Keeney, G L, Fogarty, Z C, Vierkant, R A, Liu, S, Cho, S, Nelson, G, Ghatage, P, Gentry-Maharaj, A, Gayther, S A, Benjamin, E, Widschwendter, M, Intermaggio, M P, Rosen, B, Bernardini, M Q, Mackay, H, Oza, A, Shaw, P, Jimenez-Linan, M, Driver, K E, Alsop, J, Mack, M, Koziak, J M, Steed, H, Ewanowich, C, DeFazio, A, Chenevix-Trench, G, Fereday, S, Gao, B, Johnatty, S E, George, J, Galletta, L, Goode, E L, Kjær, S K, Huntsman, D G, Fasching, P A, Moysich, K B, Brenton, J D, Kelemen, L E
Publicado no Br J Cancer (2014)